CLINICAL_TRIALS
trial_result
· 2011-04-13
Clinical Trial Update: Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects
Summary
This trial update discusses how the Atazanavir 150L mutation influences response to subsequent HIV treatments in HIV-infected subjects.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: HIV Infection | Status: COMPLETED